Is a washout period required when switching from an Angiotensin-Converting Enzyme Inhibitor (ACEI) to an Angiotensin Receptor Blocker (ARB)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

No washout period is required when switching from an Angiotensin-Converting Enzyme Inhibitor (ACEI) to an Angiotensin Receptor Blocker (ARB). The transition can be made directly, with the first dose of the ARB given the day after the last dose of the ACEI. This direct switch is safe because while both medication classes affect the renin-angiotensin-aldosterone system, they do so through different mechanisms. ACEIs block the conversion of angiotensin I to angiotensin II, while ARBs block the binding of angiotensin II to its receptors. There is no dangerous interaction or cumulative effect when transitioning between these medications, as supported by studies such as 1, which demonstrated the safety and efficacy of switching from an ACEI to an ARB without a washout period. However, patients should still be monitored for blood pressure changes, kidney function, and potassium levels after the switch, as individual responses may vary. It's also important to note that while a washout period isn't necessary, the full effect of the ARB may take several weeks to develop, so patience is needed when evaluating the effectiveness of the new medication.

Some key points to consider when switching from an ACEI to an ARB include:

  • Monitoring blood pressure and adjusting the dose of the ARB as needed
  • Keeping a close eye on kidney function and potassium levels, especially in patients with pre-existing kidney disease
  • Being aware of potential side effects, such as dizziness or lightheadedness, and taking steps to mitigate them
  • Considering the patient's overall health status and medical history when making the switch, as certain conditions may affect the safety and efficacy of the transition.

It's worth noting that the most recent and highest quality study, 2, actually discusses the washout period for switching from ACEI to ARNI, not ARB, and its findings may not be directly applicable to the switch from ACEI to ARB. However, the general principle of careful monitoring and individualized patient care remains relevant.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.